CONTINUE TO SITE
OR WAIT null SECS
- About Us
- Advertise
- Editorial
- Contact Us
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2025 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
The Path Forward for Infused Biosimilars in the US
Vibhu Tewary offers insight on this market segment, including a behind-the-scenes of what goes into designing a report.
In this exclusive PC Podcast interview, Vibhu Tewary, project director, IQVIA Institute for Human Data Science, discusses:
- Highlights of the company’s report surrounding the “Long-term Market Sustainability for Infused Biosimilars in the US: Foundational Analytics on Emerging Risks to Sustainability”
- The process that constructing and piecing together a report of this magnitude entails, along with where the idea itself came from
- The concept of net cost recovery
- The ongoing challenges surrounding ASP-based reimbursement
- A closed-door, multi-stakeholder virtual roundtable (based on his original report) that was previously held
The latest episode of The Pharmaceutical Commerce Podcast is available directly on Audioboom, Spotify, or iHeart.
Related Content:
